New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Autolus Therapeutics plc
AUTL
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

1B

Biotechnology

Next Earning date - 07 Nov 2024

1B

Biotechnology

Next Earning date - 07 Nov 2024

4.54USD
Shape-0.27 ( -5.52%)
Market Open
favorite-chart

Relative Strenght

31
favorite-chart

Volume Buzz

-68%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

39%

Quote Panel

Shape
Updated October 21, 2024
1W 7.51 % 1M 30.86 % 3M 6.51 % 1Y 81.03 %

Key Metrics

Shape
  • Market Cap

    1.21B


  • Shares Outstanding

    266.05M


  • Share in Float

    236.60M


  • Dividende

    0


  • Earning Date

    07 Nov 2024


  • Price Target

    4.535


  • Average Volume

    797884


  • Beta

    2.031


  • Range

    2.21-7.45


  • Industry

    Biotechnology


  • Website

    https://www.autolus.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

98.31x

P/S Ratio

2.29x

P/B Ratio

0.5

Debt/Equity

-1906.6%

Net Margin

$-1.1

EPS

How AUTL compares to sector?

P/E Ratio

Relative Strength

Shape

AUTL

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$61M

ShapeNaN%

2025-Revenue

$0.71

Shape-223%

2025-EPS

$61M

Shape-8%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.47
vs -0.47

Q4.22

arrow
arrow

N/A

-0.23
vs -0.51

Q1.23

arrow
arrow

N/A

-0.23
vs -0.41

Q2.23

arrow
arrow

N/A

-0.26
vs -0.46

Q3.23

arrow
arrow

N/A

-0.26
vs -0.47

Q4.23

arrow
arrow

N/A

-0.44
vs -0.23

Q1.24

arrow
arrow

N/A

-0.24
vs -0.23

Q2.24

arrow
arrow

N/A

-0.22
vs -0.26

Q3.24

arrow
arrow

N/A

-0.21
vs -0.26

Q4.24

arrow
arrow

N/A

-0.20
vs -0.44

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+904%

2.4M  vs 236K

Q4.22

arrow
arrow

+365%

3.8M  vs 823K

Q1.23

arrow
arrow

+678%

1.3M  vs 166K

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

-83%

406K  vs 2.4M

Q4.23

arrow
arrow

-54%

1.8M  vs 3.8M

Q1.24

arrow
arrow

+681%

10.1M  vs 1.3M

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

-52%

193.8K  vs 406K

Q4.24

arrow
arrow

-90%

168.8K  vs 1.8M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-27%

-0.27
vs -0.20

Q4.22

arrow
arrow

-9%

-0.09
vs -0.27

Q1.23

arrow
arrow

-15%

-0.15
vs -0.09

Q2.23

arrow
arrow

-20%

-0.20
vs -0.15

Q3.23

arrow
arrow

-25%

-0.25
vs -0.20

Q4.23

arrow
arrow

-69%

-0.69
vs -0.25

Q1.24

arrow
arrow

-9%

-0.09
vs -0.69

Q2.24

arrow
arrow

-11%

-0.11
vs -0.09

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

63

63
vs 64

-2%

Q4.22

arrow
arrow

71

71
vs 63

13%

Q1.23

arrow
arrow

65

65
vs 71

-8%

Q2.23

arrow
arrow

69

69
vs 65

6%

Q3.23

arrow
arrow

69

69
vs 69

NA

Q4.23

arrow
arrow

98

98
vs 69

42%

Q1.24

arrow
arrow

121

121
vs 98

23%

Q2.24

arrow
arrow

110

110
vs 121

-9%

Earnings Growth

Latest News